Intra-Cellular Therapies Stock Predictions

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

ITCI
Intra-Cellular Therapies

Last Price:

$131.27

Seasonality Move:

6.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest in the Future of AI-Driven Marketing

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 30% based on the past 11 years of stock performance.
Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Is Intra-Cellular Therapies Stock Undervalued?

The current Intra-Cellular Therapies [ITCI] share price is $131.26. The Score for ITCI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 30% based on the past 11 years of stock performance.

Intra-Cellular Therapies Stock Rating

Buy

Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

131.40

52-Week Low:

63.87

Prediction Charts

Market Cap:

14B

Price in USD:

131.26

Volume:

1.5M

Beta:

1.07

Technical Analysis

SMA50:

120.42

SMA100:

102.19

SMA200:

87.81

52-Wk Change:

103.28%

Stock Predictions

Is Intra-Cellular Therapies stock public?

Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?

The Intra-Cellular Therapies stock price is 131.26 USD today.
How to buy Intra-Cellular Therapies stock online?

You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Feb-21	128.77	128.60	128.77	128.52
Feb-25	128.58	128.58	128.74	128.31
Feb-26	129.00	128.46	129.00	128.04
Feb-27	128.59	128.26	128.63	128.20
Feb-28	128.49	128.20	128.50	128.06
Mar-3	131.33	131.26	131.35	131.20
Mar-4	131.26	131.24	131.36	131.21
Mar-5	131.28	131.19	131.35	131.18
Mar-6	131.23	131.25	131.28	131.20
Mar-7	131.30	131.24	131.32	131.21
Mar-11	131.24	131.24	131.37	131.23
Mar-12	131.25	131.25	131.33	131.19
Mar-13	131.25	131.36	131.38	131.22
Mar-14	131.28	131.26	131.40	131.24

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $3.58 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.